A retrospective cohort study of the risk factors and outcomes of antibiotic resistance in the intensive care unit

被引:0
作者
Mustapha, Mohd Tarmimi [1 ]
Hassan, Wan Mohd Nazaruddin Wan [1 ]
Mokhtar, Ariffin Marzuki [1 ]
Shukeri, Wan Fadzlina Wan Muhd [1 ]
Mazlan, Mohd Zulfakar [1 ]
机构
[1] Univ Sains Malaysia USM, Sch Med Sci, Dept Anesthesiol & Intens Care, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia
关键词
Antibiotic; Resistance; Intensive care unit; Risk factors; Mortality;
D O I
10.35975/apic.v25i4.1571
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Antibiotic resistance remains a major problem in the intensive care units (ICU). Various risk factors have been documented by various researchers. Similarly some factors have been identified to influence the outcome after the antibiotic resistance has been developed in the patients. This retrospective study aimed to identify and document the risk factors and outcomes in ICU of our hospital. Methodology: This retrospective, single-centre cohort study, involved 440 patients, treated in the ICU during January 2017 to December 2019. The medical records of the enrolled patients were reviewed to identify the risk factors and outcomes of antibiotic resistance. The data were analysed using the Statistical Package for the Social Sciences (SPSS) software version 26 (SPSS Inc., USA). Statistical tests used included chi-square test, Fisher's exact test, independent t-test, the Mann-Whitney test and simple or multiple logistic regression tests as per requirement. Results: The prevalence of antibiotic resistance was 22.3%. The odds for antibiotic resistance were increased 2.90 times with medical admission [Odds ratio (OR) 2.897; 95% confidence interval (CI) 1.560, 5.379; p = 0.01] and 3.42 times with carbapenem usage (OR 3.418; 95% CI 1.790, 6.526; p < 0.001). The odds were 73.2% lower with nitroimidazole usage (beta= -1.318, OR 0.268; 95% CI 0.131, 0.546; p < 0.001) and 62.2% lower with macrolide usage (beta = -0.973, OR 0.378; 95% CI 0.150, 0.950; p = 0.039). Each day of antibiotic usage increased the odds of antibiotic resistance by 1.07 times (OR 1.072; 95% CI 1.037, 1.111; p < 0.001), and each additional antibiotic prescribed increased the odds of antibiotic resistance by 1.72 times (OR 1.717; 95% CI 1.218, 2.423; p = 0.02). The antibiotic resistance mortality rate was 68.4%. Conclusions: Antibiotic resistance increased the mortality rate in the ICU, and the risk factors increased with medical-related admission, carbapenem usage, longer antibiotics duration and more antibiotic usage.
引用
收藏
页码:428 / 435
页数:8
相关论文
共 16 条
  • [1] Epidemiology of Multi-Drug Resistant Organisms in a Teaching Hospital in Oman: A One-Year Hospital-Based Study
    Balkhair, Abdullah
    Al-Farsi, Yahya M.
    Al-Muharrmi, Zakariya
    Al-Rashdi, Raiya
    Al-Jabri, Mansoor
    Neilson, Fatma
    Al-Adawi, Sara S.
    El-Beeli, Marah
    Al-Adawi, Samir
    [J]. SCIENTIFIC WORLD JOURNAL, 2014,
  • [2] Callejo-Torre Fernando, 2016, Infez Med, V24, P201
  • [3] The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco
    El Mekes, Adel
    Zahlane, Kawtar
    Said, Loubna Ait
    Ouafi, Ahmed Tadlaoui
    Barakate, Mustapha
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (04) : 637 - 643
  • [4] Prevalence and risk factors of MRSA, ESBL and MDR bacterial colonization upon admission to an Egyptian medical ICU
    Fouda, Ragai
    Soliman, May Sherif
    ElAnany, Mervat Gaber
    Abadeer, Maggie
    Soliman, Ghada
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (04): : 329 - 336
  • [5] Carbapenem resistant Acinetobacter Species infection in intensive care unit: The outcome and risk factors of mortality
    Hassan, Wan Mohd Nazaruddin Wan
    Puzizer, Mohd Samsul
    Deris, Zakuan Zaini
    Zaini, Rhendra Hardy Mohamad
    [J]. BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2020, 19 (01): : 98 - 104
  • [6] A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients
    Hu, Yangmin
    Ping, Yanting
    Li, Leiqing
    Xu, Huimin
    Yan, Xiaofeng
    Dai, Haibin
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (03): : 208 - 213
  • [7] Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection
    Kallel, Hatem
    Houcke, Stephanie
    Resiere, Dabor
    Roy, Michaella
    Mayence, Claire
    Mathien, Cyrille
    Mootien, Joy
    Demar, Magalie
    Hommel, Didier
    Djossou, Felix
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (01) : 508 - 514
  • [8] Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis
    Liu, Pin
    Li, Xuan
    Luo, Mei
    Xu, Xuan
    Su, Kewen
    Chen, Shuai
    Qing, Ying
    Li, Yingli
    Qiu, Jingfu
    [J]. MICROBIAL DRUG RESISTANCE, 2018, 24 (02) : 190 - 198
  • [9] Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome
    Magira, E. E.
    Islam, S.
    Niederman, M. S.
    [J]. MEDICINA INTENSIVA, 2018, 42 (04) : 225 - 234
  • [10] Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms
    Martin-Loeches, Ignacio
    Torres, Antonio
    Rinaudo, Mariano
    Terraneo, Silvia
    de Rosa, Francesca
    Ramirez, Paula
    Diaz, Emili
    Fernandez-Barat, Laia
    Luigi Li Bassi, Gian
    Ferrer, Miquel
    [J]. JOURNAL OF INFECTION, 2015, 70 (03) : 213 - 222